Barrie J Carter

Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial.

Thomas Ferkol, Carlos Milla, Frank Accurso, 2007, Human gene therapy.

Adeno-associated virus vectors in clinical trials.

B. Carter, Barrie J Carter, 2005, Human gene therapy.

A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies.

Terence R Flotte, Phyllis Gardner, T. Flotte, 2002, Human gene therapy.

Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.

Terence R Flotte, Suzanne Beck, T. Flotte, 2003, Human gene therapy.

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi

Brian L. Gilmore, S. Harper, B. Davidson, 2008, Proceedings of the National Academy of Sciences.

Effect of gene therapy on visual function in Leber's congenital amaurosis.

Nick Tyler, Fred W Fitzke, Gary S Rubin, 2008, The New England journal of medicine.